SCHEMBL280044

SCHEMBL280044

O=C1C=CNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7420591 0.84
SCHEMBL20183688 0.72
SCHEMBL307585 0.71
SCHEMBL10915 0.71
Hydrochloric Acid SCHEMBL17363299 0.69
Hydrogen Sulfide SCHEMBL27545450 0.69
SCHEMBL279855 0.67
SCHEMBL4936431 0.67
Pyrrolidine SCHEMBL15346082 0.65 ALDH1A1 (0.35)
SCHEMBL5029860 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104031142-A Synthesis method of highly specific folic acid complete antigen and application of folic acid complete antigen UNIV JIANGNAN 2014-09-10 CN claimed
EP-0393711-A2 Silver halide photographic material FUJI PHOTO FILM CO., LTD. (JP) 1990-10-24 EP claimed
JP-3215469-A None JP disclosed
JP-51146496-A None JP disclosed
JP-51146496-A None JP disclosed
EP-4551556-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS Vividion Therapeutics, Inc. (US) 2025-05-14 EP disclosed
CN-119859377-A Polyacetal resin composition 旭化成株式会社 2025-04-22 CN disclosed
WO-2024010784-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS, INC. (US) 2024-01-11 WO disclosed
EP-4201923-A1 5-SUBSTITUTED 2,3-DIHYDROPYRIDIN-4-ONES AND PROCESS FOR PREPARING THE SAME Karl-Franzens-Universität Graz (AT) 2023-06-28 EP disclosed
EP-4201923-A1 5-SUBSTITUTED 2,3-DIHYDROPYRIDIN-4-ONES AND PROCESS FOR PREPARING THE SAME Karl-Franzens-Universität Graz (AT) 2023-06-28 EP disclosed
CN-110337437-B Substituted pyrazolopyrimidinones as PDE2 inhibitors 达特神经科学有限公司 2023-02-03 CN disclosed
CN-1044656-A Pyrazolopyridine compound and preparation method thereof FUJISAWA PHARMACEUTICAL CO (JP) 1990-08-15 CN disclosed
EP-0379979-A1 Pyrazolopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-08-01 EP disclosed
US-4868173-A CONTAIN AMINE SALT GROUP ICI PHARMA (FR) 1989-09-19 US disclosed
EP-0119087-B1 2-(2-HYDROXY-4-(SUBSTITUTED) PHENYL) PIPERIDINES PFIZER INC. (US) 1988-10-05 EP disclosed
EP-0182633-A2 Cephalosporin derivatives ICI PHARMA (FR) 1986-05-28 EP disclosed
US-4529732-A Analgesics PFIZER INC. (US) 1985-07-16 US disclosed
EP-0119087-A1 2-(2-Hydroxy-4-(substituted) phenyl) piperidines PFIZER INC. (US) 1984-09-19 EP disclosed
JP-S51146496-A PROCESS FOR PREPARING NOVEL 4-OXO- 1,2,3,4-TETRAHYDROPYRIDO (2,3-D)PYR IMIDINE DERIVATIVES HISAMITSU PHARMACEUT CO INC 1976-12-16 JP disclosed
JP-S51146496-A PROCESS FOR PREPARING NOVEL 4-OXO- 1,2,3,4-TETRAHYDROPYRIDO (2,3-D)PYR IMIDINE DERIVATIVES HISAMITSU PHARMACEUT CO INC 1976-12-16 JP disclosed